Clinical Trial

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Study acronym: GA22
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 13, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will describe the interplay between the gut hormones GIP and CCK and their regulation of blood flow to the large vessels in patients with Postural Orthostatic Tachycardia Syndrome (POTS) and GIP, CCK and GLP-1 in healthy. This is addressed by hormone infusions during MR-scans of the abdomen and intake of oral glucose.
Trial Details
NCT Number NCT07019519
Lead Sponsor University of Copenhagen
Collaborators: Rigshospitalet, Denmark
Conditions Postural Orthostatic Tachycardia Syndrome (POTS), Healthy
Enrollment 30 participants
Start Date 2025-03-15
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-06-13